交易中 09-16 15:37:56 美东时间
-0.029
-18.40%
Psyence Biomedical shares are trading higher by 73% during Thursday's session. The company announced the export of nature-derived psilocybin to Australia.
07-26 01:24
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Th...
03-21 02:49
On Wednesday, Psyence Biomedical announced the approval for its Phase IIb study to examine the use of psilocybin as a treatment for Adjustment Disorder due to a recent cancer diagnosis in the palliative care context.
03-09 01:15
Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
01-30 03:09